877-202-0205     support@chemchart.com     @chemchart
Sign In    Register
   Reset Filters

Cardiovascular system drug, Cycloalkanes


Cyclic compounds (6)
Drugs acting on the cardiovascular system (6)
Antihypertensive agents (5)
Cyclopropanes (4)
Three-membered rings (4)
Antiandrogens (3)
Antimineralocorticoids (3)
Diuretics (3)
Drugs acting on the genito-urinary system (3)
Hormonal agents (3)
Potassium-sparing diuretics (3)
Sex hormones (3)
Spiro compounds (3)
Systemic hormonal preparations (3)
Antihypertensive agent (2)
Five-membered rings (2)
Acids (1)
Adamantanes (1)
Agents acting on the renin-angiotensin system (1)
Alcohols (1)
Amines (1)
Angiotensin II receptor antagonists (1)
Antianginals (1)
Antiarrhythmic agents (1)
Bases (chemistry) (1)
Beta blockers (1)
Carboxylic acids (1)
Cyclopentanes (1)
Imidazolines (1)
Organic acids (1)
Progestogens (1)
Tetrazoles (1)

Cibenzoline (53267-01-9)  
cifenline  ·  cibenzoline succinate  ·  cifenline succinate
Cibenzoline (or cifenline) is a Class Ia antiarrhythmic. Pituxate & Ecipramidil are other gem-diphenyl cyclopropanyl drugs.
Adaprolol (101479-70-3)  
Adaprolol is a beta blocker.
Prorenone (49848-04-6)  
Prorenone (developmental code name SC-23133) is a steroidal antimineralocorticoid of the spirolactone group related to spironolactone that was never marketed. It is the lactonic form of prorenoic acid (prorenoate), and prorenoate potassium (SC-23992), the potassium salt of prorenoic acid, also exists. Prorenoate potassium is about 8 times more potent than spironolactone as an antimineralocorticoid in animals, and it may act as a prodrug to prorenone.
Abitesartan (137882-98-5)  
Abitesartan (INN) is an Angiotensin II receptor antagonist.
Spirorenone (74220-07-8)  
6 beta, 7 beta, 15 beta, 16 beta-dimethylene-1,4-androstadiene-(17(beta-1')-spiro-5')-perhydrofuran-2',3-dione
Spirorenone (INN) (developmental code name ZK-35973) is a steroidal antimineralocorticoid of the spirolactone group that was never marketed. Spirorenone possesses 5–8 times the antimineralocorticoid activity of spironolactone in animal studies. The initial discovery of spirorenone was deemed a great success, as no compound with greater antimineralocorticoid activity had been developed since spironolactone in 1957.
Related searches
Cardiovascular system drug